"Let's de-risk your clinical program"

We are here to give you confidence in your preclinical data and allow you to make high quality judgments early in the drug development process. Uncover the world of PreciseInhale ® where we will deliver:

  • Unparalleled precision and control
  • Time and money savings with increased precision
  • Minimum substance amount needed for studies
  • A world of exposure options which are closer to IVIVC

Book a free consultation

Talk to us and find out exactly how PreciseInhale® can deliver better data for your pre-clinical studies. Book a consultation with Paolo Raffaelli, our Chief Commercial Officer today by filling out the form.









    "Let's de-risk your clinical program"

    We are here to give you confidence in your preclinical data and allow you to make high quality judgments early in the drug development process. Uncover the world of PreciseInhale ® where we will deliver:

    • Unparalleled precision and control
    • Time and money savings with increased precision
    • Minimum substance amount needed for studies
    • A world of exposure options which are closer to IVIVC

    Book a free consultation

    Talk to us and find out exactly how PreciseInhale® can deliver better data for your pre-clinical studies. Book a consultation with Paolo Raffaelli, our Chief Commercial Officer today by filling out the form.









      Why do our customers trust PreciseInhale®?

      Listen to pioneers in the drug development field explain how PreciseInhale ® is “a better tool for better answers” and a “unique exposure system that mimics the situation in humans”.

      Our customers care about quality data because it allows them to make decisions with confidence. PreciseInhale ® is built to deliver quality and precision by administering “a very precise dose” of your aerosolized drug.

      Why not join a growing community of researchers, who are now facing a new sense of clarity and confidence in their pre-clinical decisionmaking, thanks to PreciseInhale ® ?

      PreciseInhale®: Precision dosing

      PreciseInhale ® is a unique methodology that gives you unprecedented control over your aerosol, the dose and the strength of the air pressure. There are two core innovations that make PreciseInhale ® such a valuable tool for pre-clinical research.

      Firstly, the design of the dispensing unit allows you to separate the generation of the aerosols from the dispensing. This two step process means that only the desired aerosols are dispensed so that you can be certain of the response that you are measuring. You not only know exactly how much drug is delivered but also the state of the drug as it enters the lungs.

      Secondly, PreciseInhale ® comes with a patented software that measures and monitors aerosols and breathing patterns in real time. This allows you to customize your aerosol producing and generate detailed PK data including particle size, distribution data as well as Tmax and Cmax curves.

      dekorativ

      Why PreciseInhale®?

      icon

      PreciseInhale®: unparalleled precision and control

      Control your aerosols and your results, keeping standard deviation below 10%.

      icon

      Confidence in early decision making

      Accurate decisions in pre-clinical drug development can only come from accurate data. PreciseInhale® delivers accurate and predictive data that reduces the number of tests needed and accelerates drug discovery. PreciseInhale® gives you confidence to make early decisions in the clinical process.

      icon

      A complete PK study with minimal amount of substance

      Precision Dosing is a low-consumption, one-animal-at-a-time methodology. Only small amounts of test substance are required. With lifelike controlled doses in individual exposures, only biologic deviations make it into the results –eliminating all extraneous experimental deviations.

      icon

      Closer to IVIVC with a world of exposure options

      With PreciseInhale®, data on a single aerosol can be generated and compared across a range of exposure modules from a single source – whether dry powder, inhaler or nebulized solution.

      We’re the Inhalation Scientists. Try us!

      Talk to Paolo.

      Paolo Raffaelli is our Chief Commercial Officer and has over 20 years experience in the life science and medical device industry. He is enthusiastic about your project and wants to help you de-risk your drug development process in the pre-clinical phase.

      ”PreciseInhale ® clearly offers the possibility to get pre-clinical research right the first time.”

      profile picture

      Paolo Raffaelli

      Chief Commercial Officer

      Book a free consultation

      Talk to us and find out exactly how PreciseInhale® can deliver better data for your pre-clinical studies. Book a consultation with Paolo Raffaelli, our Chief Commercial Officer today by filling out the form.